Bioreduction of silver nanoparticles from aerial parts of Euphorbia hirta L. (EH-ET) and its potent anticancer activities against neuroblastoma cell lines

Euphorbia hirta L. (Family: Euphorbiaceae) is a versatile medicinal plant and enriched with novel bioactive molecules and possess broad-spectrum pharmacological actions. Present work is aiming to synthesis and characterize of silver nanoparticles (AgNPs) by bioreduction method an using ethanolic extract of aerial parts of Euphorbia hirta L. (EH-ET). The synthesized AgNPs observed by a color change of source solution (as AgNPs) and further confirmed by the UV-Visible spectroscopic technique. The AgNPs synthesized were characterized by Scanning Electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR) and Zeta potential analysis. The synthesized AgNPs are polydispersed and some places it’s agglomerated. The particle size EH-ET silver nanoparticles were analyzed using Beckman coulter particle size analyzer (DelsaTM Nano common). The average size of the particles size noted in 2.9-206.3 nm. Anticancer activity of EH-ET Silver nanoparticles was tested against neuroblastoma cells (SH-SY5Y) and breast cancer cells (SH-SY5Y) and cytotoxicity were tested in vero cells by MTT assay. The preliminary confirmation of the synthesized AgNPs by the present method was made by the appearance of reddish brown color and the visible absorption peak at 429.5 nm. SEM image revealed that AgNPs synthesized were spherical in shape and silver nanoparticles were in the size range of 2.9 to 206.3 nm. FT-IR spectra showed the peaks corresponding to functional groups C=O, -C=C and -OH, which actively participated in bio-reduction and subsequent stabilization reactions in the synthesis of AgNPs. The obtained nanoparticles showed promising anticancer activity against neuroblastoma cells (SH-SY5Yc) and breast cancer cells (MCF-7) with IC50 values of 29.85 and 335 µg/mL, respectively. Whereas, the nanoparticles did not show any activity against vero cell lines. The synthesized silver nanoparticles using an ethanolic extract of Euphorbia hirta L. would be helpful for the preparation of potent cytotoxicity agents to destroy cancer cells

Bioreduction of silver nanoparticles from aerial parts of <em>Euphorbia hirta</em> L. (EH-ET) and its potent anticancer activities against neuroblastoma cell lines

132-136Euphorbia hirta L. (Family: Euphorbiaceae) is a versatile medicinal plant and enriched with novel bioactive molecules and possess broad-spectrum pharmacological actions. Present work is aiming to synthesis and characterize of silver nanoparticles (AgNPs) by bioreduction method an using ethanolic extract of aerial parts of Euphorbia hirta L. (EH-ET). The synthesized AgNPs observed by a color change of source solution (as AgNPs) and further confirmed by the UV-Visible spectroscopic technique. The AgNPs synthesized were characterized by Scanning Electron microscopy (SEM), Fourier transform infrared spectroscopy (FT-IR) and Zeta potential analysis. The synthesized AgNPs are polydispersed and some places it&rsquo;s agglomerated. The particle size EH-ET silver nanoparticles were analyzed using Beckman coulter particle size analyzer (DelsaTM Nano common). The average size of the particles size noted in 2.9-206.3 nm. Anticancer activity of EH-ET Silver nanoparticles was tested against neuroblastoma cells (SH-SY5Y) and breast cancer cells (SH-SY5Y) and cytotoxicity were tested in vero cells by MTT assay. The preliminary confirmation of the synthesized AgNPs by the present method was made by the appearance of reddish brown color and the visible absorption peak at 429.5 nm. SEM image revealed that AgNPs synthesized were spherical in shape and silver nanoparticles were in the size range of 2.9 to 206.3 nm. FT-IR spectra showed the peaks corresponding to functional groups C=O, -C=C and -OH, which actively participated in bio-reduction and subsequent stabilization reactions in the synthesis of AgNPs. The obtained nanoparticles showed promising anticancer activity against neuroblastoma cells (SH-SY5Yc) and breast cancer cells (MCF-7) with IC50 values of 29.85 and 335 &micro;g/mL, respectively. Whereas, the nanoparticles did not show any activity against vero cell lines. The synthesized silver nanoparticles using an ethanolic extract of Euphorbia hirta L. would be helpful for the preparation of potent cytotoxicity agents to destroy cancer cells

Identification and characterization of a potent anticancer fraction from the leaf extracts of <i style="mso-bidi-font-style: normal">Moringa oleifera</i> L.

98-103Anticancer potential of <i style="mso-bidi-font-style: normal">Moringa oleifera L. extracts have been well established. However, there are no reports on the isolated molecules/fractions from these extracts which are responsible for the anticancer/cytotoxic activity. Thus, in the present study, we explored the same. The n-hexane, chloroform, ethyl acetate, methanol extracts of the M. oleifera leaves and 15 fractions (F1 to F15) of ethyl acetate extract were evaluated for their <i style="mso-bidi-font-style: normal">in vitro and in vivo anticancer activity using Hep-2 cell lines and Dalton’s lymphoma ascites model in mice, respectively. Among the tested samples, the F1 fraction showed potential cytotoxic effect in Hep-2 cell lines with a CTC50 value of 12.5 ± 0.5 µg/ml. In vivo studies with the doses 5 and 10 mg/kg, p.o. demonstrated significant reduction in body weight and increased the mean survival time compared to the control group. These results were also comparable to the standard, 5-Fluorouracil, treated animals. We have also successfully isolated and characterized the anticancer fraction, F1 from the leaves of M. oleifera L

Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors

Tumor necrosis factor related apoptosis inducing ligand (TRAIL) proved to be a promising new target for colorectal cancer treatment. Elevated expression of TRAIL protein in tumor cells distinguishes it from healthy cells, thereby delivering the drug at the specific site. Here, we formulated oxaliplatin immunohybrid nanoparticles (OIHNPs) to deliver oxaliplatin and anti-TRAIL for colorectal cancer treatment in xenograft tumor models. The polymeric chitosan layer binds to the lipid film with the mixture of phospholipids by an ultra sound method followed by conjugating with thiolated antibody using DSPE-PEG-mal3400, resulting in the formation of OIHNPs. The polymer layer helps in more encapsulation of the drug (71 ± 0.09%) with appreciable particle size (95 ± 0.01 nm), and lipid layer prevents degradation of the drug in serum by preventing nanoparticle aggregation. OIHNPs have shown a 4-fold decrease in the IC50 value compared to oxaliplatin in HT-29 cells by the MTT assay. These immuno-nanoparticles represent the successful uptake and internalization of oxaliplatin in HT-29 cells rather than in MCF-7 cells determined by triple fluorescence method. Apoptotic activity in vitro of OIHNPs was determined by the change in the mitochondria membrane potential that further elevates its anti-tumor property. Furthermore, the conjugated nanoparticles can effectively deliver the drug to the tumor sites, which can be attributed to its ability in reducing tumor mass and tumor volume in xenograft tumor models in vivo along with sustaining its release in vitro. These findings indicated that the oxaliplatin immuno-hybrid nanoparticles would be a promising nano-sized active targeted formulation for colorectal-tumor targeted therapy